EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Optimising Secondary Prevention in Patients Undergoing Carotid Surgery: A Cohort Study Assessing Lipid Lowering and Antithrombotic Therapy

Jing Yi Kwan, Alex Harper, Mehak Sood, Eleanor Carney, Ciara Doyle, Fabio Stocco, Henry Davies, David Julian Ashbridge Scott, Marc A Bailey, Patrick A Coughlin

European Journal of Vascular and Endovascular Surgery · 2026

DOI: 10.1016/j.ejvs.2025.04.007 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2026. Verfasst von Jing Yi Kwan und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Leeds Vascular Institute, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK; The Leeds Institute of Cardiovascular and Metab…. Hauptthemen laut MEDLINE: Secondary Prevention, Platelet Aggregation Inhibitors, Fibrinolytic Agents, Carotid Artery Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: United Kingdom and European guidelines recommend that patients with atherosclerotic carotid artery disease should be commenced on optimal cardioprotective medical therapy, specifically antiplatelet agents and lipid lowering therapy (LLT). This single centre cohort study explored the peri-operative prescription and titration of guideline directed medical therapy (GDMT) alongside low density lipoprotein cholesterol (LDL-C) levels in patients undergoing carotid intervention. METHODS: The study included 260 patients who underwent carotid intervention from 1 January 2017 to 31 December 2021. Electronic hospital records were checked for data on demographics, comorbidities, antiplatelet and LLT prescriptions, and cholesterol results. Data from four time points were obtained: prior to the index event; at the time of admission for carotid intervention; at discharge following intervention; and at one year. RESULTS: Antiplatelet therapy was indicated in one fifth and high intensity LLT in 39% of patients who were not on cardioprotective medications prior to the index event. From the time of admission for carotid intervention to discharge, the proportion of patients who were prescribed antithrombotic therapy (82% vs. 100%; p < .001) and LLT (88% vs. 94%; p = .004) statistically significantly increased. Mean LDL-C levels statistically significantly reduced from 2.2 mmol/L pre-admission to 1.8 mmol/L at one year follow up (p = .026). However, only 53% of patients achieved an LDL-C target of < 1.8 mmol/L one year following intervention. All patients who did not achieve the LDL-C target had scope for uptitration of statin or co-prescription of adjuvant LLT agents, including ezetimibe, inclisiran, and PCSK9i. CONCLUSION: Underutilisation of LLT prior to incident stroke was identified as a key tractable problem. Admission for carotid intervention is associated with an increase in GDMT and reduction in LDL-C levels. There is scope for improvement and a need for long term community based management of cardiovascular risk, specifically risk assessment, initiation and ongoing uptitration of LLT, and regular monitoring of LDL-C levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Secondary PreventionPlatelet Aggregation InhibitorsFibrinolytic AgentsCarotid Artery DiseasesEndarterectomy, CarotidHypolipidemic AgentsStrokeHumansMaleFemaleAgedMiddle AgedCholesterol, LDLAged, 80 and overTreatment OutcomeRetrospective StudiesHydroxymethylglutaryl-CoA Reductase InhibitorsRisk Factors

Stichwörter der Autor:innen

Antiplatelet agentsCarotid endarterectomyCholesterolHypolipidaemic agentsStrokeTransient ischaemic attack

Substanzen

Platelet Aggregation InhibitorsFibrinolytic AgentsCholesterol, LDLHypolipidemic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • The Leeds Vascular Institute, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK; The Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
  • The Leeds Vascular Institute, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • The Leeds Vascular Institute, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK; The Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK. Ele…

Förderung

  • National Institute for Health and Care Research
  • British Heart Foundation

Zitieren

APA

Kwan, J. Y., Harper, A., Sood, M., Carney, E., Doyle, C., Stocco, F., Davies, H., Scott, D. J. A., Bailey, M. A., & Coughlin, P. A. (2026). Optimising Secondary Prevention in Patients Undergoing Carotid Surgery: A Cohort Study Assessing Lipid Lowering and Antithrombotic Therapy. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.04.007

Vancouver

Kwan JY, Harper A, Sood M, Carney E, Doyle C, Stocco F, et al. Optimising Secondary Prevention in Patients Undergoing Carotid Surgery: A Cohort Study Assessing Lipid Lowering and Antithrombotic Therapy. European Journal of Vascular and Endovascular Surgery. 2026. doi:10.1016/j.ejvs.2025.04.007

BibTeX
@article{Kwan2026,
  author = {Kwan, Jing Yi and Harper, Alex and Sood, Mehak and Carney, Eleanor and Doyle, Ciara and Stocco, Fabio and Davies, Henry and Scott, David Julian Ashbridge and Bailey, Marc A and Coughlin, Patrick A},
  title = {Optimising Secondary Prevention in Patients Undergoing Carotid Surgery: A Cohort Study Assessing Lipid Lowering and Antithrombotic Therapy},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2026},
  doi = {10.1016/j.ejvs.2025.04.007}
}
Kostenlos starten →